The global US Clinical Trial Services Market is expected to reach US$39.61 billion by 2030 from US$25.57 billion in 2025, at ...

But while platform trials have the potential to be more effective and less expensive than traditional trials, challenges ...

Market is expected to witness a CAGR of 5% by 2029. The key factors driving the pharma CCO market growth are growing R&D ...

The report "Heavy Construction Equipment Market by Machinery Type (Earthmoving equipment, Material Handling Equipment, Heavy ...

The study was published in March in the journal NEJM AI. Researchers conducted a trial with 106 people who used Therabot, a ...

Pentagon says Guam could be 1st target of Chinese missiles during Taiwan invasion ...

The AI in Life Science Market is anticipated to experience a remarkable compound annual growth rate (CAGR) of around 25% in ...

Ex-Intel head says TSMC’s new investment will not resurrect US chip sector Read the Market Summary Here:- Highlighted with 36 tables and 83 figures, this 153-page report ?North America ...

H.C. Wainwright analyst Ed Arce affirms a Buy rating on shares of Inventiva (IVA) after the company announced the completion of patient ...

Delcath's Q4 sales exceeded expectations due to HEPZATO KIT adoption. Discover insights into its profitability, CHOPIN trial ...

These two general immune response findings, immune response at baseline and increasing immune response over time, were also observed in the Phase IIb clinical trial for HLA-A*02 only patients. These ...